GO:0098626 methylseleninic acid reductase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098626 methylseleninic acid reductase activity is a molecular_function defined as the catalysis of NADPH + H+ + CH3SeO2H = NADP+ + CH3SeOH + H2O.
• The reaction converts methylseleninic acid (MSA) to methylselenol, a monomethylated selenium metabolite considered critical for cancer chemoprevention.
• Methylselenol produced in vivo from MSA can induce toxic protein aggregation in Saccharomyces cerevisiae, linking this activity to proteostasis.
• MSA, the substrate of this activity, has been shown to downregulate hypoxia-inducible factor-1alpha in invasive prostate cancer.
• MSA elevates the Nrf2-GPX4 axis to relieve endothelial dysfunction and ferroptosis induced by arsenic exposure.
• The activity is part of selenium metabolism, where chemical forms of selenium determine cancer-preventive efficacy.
Description
GO:0098626 methylseleninic acid reductase activity is a molecular_function that catalyzes the NADPH-dependent reduction of methylseleninic acid (CH3SeO2H) to methylselenol (CH3SeOH), consuming a proton and producing NADP+ and water. This activity sits at the heart of selenium chemoprevention because methylselenol is widely regarded as the critical monomethylated selenium metabolite responsible for the anticancer effects of methylseleninic acid (MSA). Understanding this enzymatic step is therefore essential for researchers studying selenium biology, redox regulation, and cancer prevention. The reaction is experimentally tractable: MSA is a stable, water-soluble selenium compound that is reduced in vivo to methylselenol, and this product can be detected through its biological consequences, such as protein aggregation in yeast. In mammalian systems, MSA treatment has been linked to downregulation of hypoxia-inducible factor-1alpha in invasive prostate cancer, elevation of the Nrf2-GPX4 axis to counteract arsenic-induced endothelial ferroptosis, and protection against gamma-irradiation-induced testicular damage via the JAK/STAT pathway. These findings make GO:0098626 a focal point for mechanistic studies of selenium-dependent redox control. For biomedical researchers, GO:0098626 provides a precise ontological anchor for experiments that manipulate selenium metabolism. Because the activity is defined by a specific redox reaction, it can be interrogated with genetic knockouts, point mutations, and metabolic tracing, and it connects directly to disease models in oncology, toxicology, and radiation biology. This article summarizes the definition, mechanism, key genes, disease links, and research methods relevant to GO:0098626.
methylseleninic acid reductase activity At A Glance
| GO ID | GO:0098626 |
|---|---|
| GO term | methylseleninic acid reductase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Catalysis of NADPH + H+ + CH3SeO2H = NADP+ + CH3SeOH + H2O |
| Substrate | Methylseleninic acid (CH3SeO2H) |
| Product | Methylselenol (CH3SeOH) |
| Cofactor | NADPH |
| Reaction byproducts | NADP+ and H2O |
What Is GO:0098626?
In simple terms, GO:0098626 methylseleninic acid reductase activity is the enzyme activity that uses NADPH to convert methylseleninic acid into methylselenol. Formally, it catalyzes the reaction NADPH + H+ + CH3SeO2H = NADP+ + CH3SeOH + H2O. The activity belongs to the molecular_function ontology and has no listed synonyms in QuickGO. Its biological significance derives from the product methylselenol, a monomethylated selenium metabolite that is critical for cancer chemoprevention and that can trigger toxic protein aggregation when produced in vivo.
Why Is methylseleninic acid reductase activity Important in Cell Biology?
GO:0098626 is important because it defines the enzymatic step that generates methylselenol, the monomethylated selenium metabolite widely considered essential for the cancer-preventive action of methylseleninic acid. This activity links dietary or pharmacological selenium exposure to redox signaling, proteostasis, and cell survival, and it has been implicated in diverse biological outcomes ranging from protein aggregation in yeast to protection against arsenic-induced endothelial ferroptosis and radiation-induced testicular damage. Because the reaction is chemically explicit, it offers a precise target for genetic and pharmacological dissection of selenium metabolism in disease models.
• Defines the NADPH-dependent reduction that produces methylselenol, the key monomethylated selenium metabolite for cancer chemoprevention.
• Connects selenium chemical form to anticancer efficacy, as reviewed for different selenium compounds.
• Methylselenol generated from MSA can induce toxic protein aggregation, linking the activity to proteostasis.
• MSA, the substrate, downregulates hypoxia-inducible factor-1alpha in invasive prostate cancer.
• MSA elevates the Nrf2-GPX4 axis and relieves arsenic-induced endothelial dysfunction and ferroptosis.
• MSA protects against gamma-irradiation-induced testicular damage via the JAK/STAT pathway.
• Methylselenoesters, which can release methylselenol, show antiproliferative activity, supporting the importance of this metabolite.
• Selenoproteins and selenium metabolism are implicated in chemoprevention of obesity-associated breast cancer.
• Provides a molecular_function anchor for interpreting selenium metabolic flux in toxicology and nutrition studies.
• Enables mechanistic comparison of inorganic, organic, and methylated selenium species in disease models.
Molecular Mechanism of methylseleninic acid reductase activity
Substrate recognition and binding of methylseleninic acid
In simple terms: The enzyme first grabs methylseleninic acid, the selenium-containing molecule it will modify.
The reaction catalyzed by GO:0098626 begins with binding of the substrate methylseleninic acid (CH3SeO2H). MSA is a stable, water-soluble monomethylated selenium compound that serves as a precursor for methylselenol in biological systems. In vivo studies in Saccharomyces cerevisiae demonstrate that MSA can be metabolized to methylselenol, confirming that the substrate is accessible to the reducing machinery of the cell. The chemical form of selenium is a major determinant of its biological activity, and MSA is specifically associated with the monomethylated metabolite pool.
NADPH-dependent reduction and cofactor usage
In simple terms: NADPH supplies the electrons that turn methylseleninic acid into methylselenol.
The defining chemistry of GO:0098626 is the consumption of NADPH and a proton to reduce CH3SeO2H to CH3SeOH, yielding NADP+ and water. This places the activity within the broader family of NADPH-dependent reductases that maintain redox balance. The requirement for NADPH links the activity to cellular reducing power and to pathways that regenerate NADPH, which is consistent with the redox-sensitive outcomes observed after MSA treatment, such as modulation of the Nrf2-GPX4 axis. Because the reaction is defined by a precise stoichiometry, it can be followed experimentally by monitoring NADPH oxidation or methylselenol formation.
Product formation: methylselenol and its fate
In simple terms: The product, methylselenol, is the reactive selenium species that does the biological work.
The product of GO:0098626 is methylselenol (CH3SeOH), a monomethylated selenium metabolite that is considered critical for cancer chemoprevention. In Saccharomyces cerevisiae, methylselenol produced in vivo from MSA or dimethyl diselenide induces toxic protein aggregation, showing that the product is not inert but can perturb proteostasis. Methylselenoesters, which can also release methylselenol, exhibit antiproliferative activity, further supporting the biological potency of this metabolite. The fate of methylselenol therefore determines whether the activity leads to protective or toxic outcomes depending on dose and context.
Downstream redox signaling and cellular responses
In simple terms: Once methylselenol is made, it can change how cells handle oxidative stress and oxygen sensing.
Methylselenol generated through GO:0098626 can influence redox-sensitive signaling. MSA treatment downregulates hypoxia-inducible factor-1alpha in invasive prostate cancer, indicating an impact on oxygen-sensing pathways. In endothelial cells, MSA elevates the Nrf2-GPX4 axis and relieves ferroptosis induced by arsenic exposure, linking the activity to antioxidant defense and lipid peroxidation control. In irradiated testicular tissue, MSA modulates the JAK/STAT pathway, suggesting broader effects on stress-responsive signaling. These observations position GO:0098626 as an entry point into selenium-dependent redox regulation.
Regulation by selenium availability and chemical form
In simple terms: How much selenium and in what form determines how active this pathway is.
The activity of GO:0098626 is influenced by the availability and chemical form of selenium. Different selenium compounds vary in their ability to generate monomethylated metabolites, and MSA is specifically associated with the monomethylated pool that is critical for chemoprevention. In yeast, both MSA and dimethyl diselenide can lead to methylselenol production and subsequent protein aggregation, indicating that multiple precursors feed into the same reactive metabolite. Selenoprotein status may also modulate outcomes, as selenoproteins have been implicated in chemoprevention of obesity-associated breast cancer.
Key Genes Involved in GO:0098626 methylseleninic acid reductase activity
The genes and proteins most relevant to GO:0098626 include selenium-metabolizing enzymes, redox regulators, and downstream effectors identified in studies of methylseleninic acid and methylselenol.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPX4 | Glutathione peroxidase that protects against lipid peroxidation | MSA elevates the Nrf2-GPX4 axis to relieve arsenic-induced ferroptosis |
| Nrf2 (NFE2L2) | Master transcription factor for antioxidant response | MSA elevates the Nrf2-GPX4 axis in endothelial cells |
| HIF1A | Hypoxia-inducible factor 1 alpha, regulator of oxygen homeostasis | MSA downregulates HIF-1alpha in invasive prostate cancer |
| JAK | Janus kinase, mediator of cytokine signaling | MSA modulates the JAK/STAT pathway in irradiated testicular tissue |
| STAT | Signal transducer and activator of transcription | MSA modulates the JAK/STAT pathway in irradiated testicular tissue |
| Selenoprotein genes (e.g., GPX family) | Selenium-containing antioxidant enzymes | Selenoproteins are implicated in chemoprevention of obesity-associated breast cancer |
| MSA-metabolizing reductases (unspecified) | Enzymes that reduce methylseleninic acid to methylselenol | Defined by GO:0098626; activity produces methylselenol in vivo |
| Dimethyl diselenide-metabolizing enzymes (unspecified) | Enzymes that generate methylselenol from dimethyl diselenide | Dimethyl diselenide also produces methylselenol and protein aggregation in yeast |
| Methylselenoester-responsive targets (unspecified) | Cellular targets of methylselenol released from methylselenoesters | Methylselenoesters show antiproliferative activity |
| Selenium transport and storage proteins (unspecified) | Proteins controlling selenium availability | Chemical forms of selenium determine cancer-preventive efficacy |
| Redox homeostasis proteins (unspecified) | Maintain NADPH/NADP+ balance | NADPH is a required cofactor for GO:0098626 |
| Proteostasis machinery (unspecified) | Chaperones and degradation systems | Methylselenol induces toxic protein aggregation in yeast |
| Apoptosis regulators (unspecified) | Control cell death in response to selenium stress | MSA and methylselenoesters show antiproliferative and anticancer effects |
| Angiogenesis regulators (unspecified) | Control blood vessel formation | MSA downregulates HIF-1alpha in prostate cancer |
| Ferroptosis regulators (unspecified) | Control iron-dependent lipid peroxidation | MSA relieves ferroptosis via Nrf2-GPX4 |
| Radiation response genes (unspecified) | Mediate cellular response to ionizing radiation | MSA protects against gamma-irradiation-induced testicular damage |
| Obesity-associated cancer genes (unspecified) | Link metabolism to cancer risk | Selenoproteins are chemopreventive in obese breast cancer models |
How Is methylseleninic acid reductase activity Regulated?
The activity defined by GO:0098626 is regulated at the level of substrate availability and cellular redox state. NADPH supply is required for the reaction, and the chemical form of selenium determines whether methylselenol is produced. Downstream, the Nrf2-GPX4 axis can be elevated by MSA, indicating feedback between selenium metabolism and antioxidant gene regulation. The JAK/STAT pathway is also modulated by MSA in vivo, suggesting cytokine-linked regulation of selenium responses. HIF-1alpha downregulation by MSA further indicates that oxygen-sensing pathways intersect with this activity.
methylseleninic acid reductase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPX4 | Ferroptosis and endothelial dysfunction | Endothelial cell knockout or overexpression of GPX4 with MSA treatment |
| HIF1A | Invasive prostate cancer | Prostate cancer cell lines with HIF1A knockdown and MSA treatment |
| JAK/STAT | Radiation-induced testicular damage | Rat model of gamma-irradiation with MSA administration |
| Selenoproteins | Obesity-associated breast cancer | Breast cancer models with altered selenoprotein expression |
| Proteostasis machinery | Protein aggregation toxicity | Saccharomyces cerevisiae treated with MSA or dimethyl diselenide |
Cancer chemoprevention and prostate cancer
Methylseleninic acid, the substrate of GO:0098626, is a monomethylated selenium metabolite critical for cancer chemoprevention. In invasive prostate cancer, MSA downregulates hypoxia-inducible factor-1alpha, suggesting that the activity may limit tumor hypoxia adaptation. Selenoproteins more broadly have chemopreventive and anticancer properties in obesity-associated breast cancer. These findings support the hypothesis that methylselenol generated by GO:0098626 mediates anticancer effects.
Ferroptosis and endothelial dysfunction
MSA elevates the Nrf2-GPX4 axis to relieve endothelial dysfunction and ferroptosis induced by arsenic exposure. Because GPX4 is a key suppressor of lipid peroxidation, this links GO:0098626 to ferroptosis regulation. The reaction product methylselenol may contribute to redox balance, although the precise mechanism remains under investigation.
Radiation injury and testicular damage
MSA has a potential protective effect against gamma-irradiation-induced testicular damage in rats, with impact on the JAK/STAT pathway. This suggests that methylselenol produced via GO:0098626 may modulate stress and inflammatory signaling after radiation exposure. The finding expands the disease relevance of this activity beyond cancer.
Protein aggregation and proteostasis
In Saccharomyces cerevisiae, methylselenol produced in vivo from MSA or dimethyl diselenide induces toxic protein aggregation. This indicates that excessive activity of GO:0098626 or excessive methylselenol production can be deleterious. The yeast model provides a tractable system to study the balance between beneficial and toxic selenium metabolites.
From methylseleninic acid reductase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate reductase abolish MSA-to-methylselenol conversion? | CRISPR knockout of the candidate gene in yeast or mammalian cells |
| Does a point mutation in the catalytic site alter NADPH consumption? | CRISPR point mutation knock-in of catalytic residues |
| Can a tagged enzyme be used to monitor localization and interaction? | CRISPR knock-in of an epitope tag at the endogenous locus |
| Does overexpression of the enzyme enhance methylselenol production? | CRISPR overexpression or cDNA overexpression |
| Does MSA protect against ferroptosis in endothelial cells? | GPX4 knockout or overexpression with MSA treatment |
| Does MSA modulate HIF-1alpha in prostate cancer? | HIF1A knockout or knockdown in prostate cancer cells |
How to Study the methylseleninic acid reductase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH oxidation assay | Consumption of NADPH by the reductase reaction | Biochemical characterization of GO:0098626 activity |
| Selenium metabolite profiling | Levels of MSA and methylselenol | Metabolic tracing in yeast or mammalian cells |
| Protein aggregation assays | Formation of toxic protein aggregates | Proteostasis studies after MSA treatment |
| Western blotting | Expression of HIF-1alpha, GPX4, Nrf2, JAK/STAT proteins | Signaling studies in cancer and endothelial cells |
| Reporter assays | Transcriptional activity of Nrf2 or STAT | Pathway activation after MSA treatment |
| Cell viability assays | Antiproliferative effects of selenium compounds | Testing methylselenoesters and MSA |
| Animal models | In vivo efficacy and toxicity | Radiation damage and cancer prevention studies |
| CRISPR knockout screens | Identification of genes required for MSA response | Functional genomics of selenium metabolism |
Metabolic tracing of selenium species
Because GO:0098626 converts MSA to methylselenol, tracing selenium metabolites is a direct way to measure activity. Yeast studies have used MSA and dimethyl diselenide to produce methylselenol in vivo and then monitored protein aggregation as a downstream readout. In mammalian systems, MSA treatment can be followed by assessing redox-sensitive endpoints such as Nrf2-GPX4 axis activation.
Redox and NADPH consumption assays
The reaction consumes NADPH and a proton, so NADPH oxidation can be used as a biochemical readout of GO:0098626 activity. Such assays are compatible with recombinant enzyme preparations or cell lysates. Coupling NADPH consumption to methylselenol detection provides a quantitative measure of catalytic efficiency.
Proteomics and aggregation analysis
Methylselenol produced from MSA induces toxic protein aggregation in Saccharomyces cerevisiae, which can be detected by proteomic and biochemical methods. Aggregation-prone proteins can be identified by mass spectrometry after MSA treatment. This approach links GO:0098626 activity to proteostasis and identifies potential toxicity mechanisms.
Cell-based signaling assays
MSA treatment affects multiple signaling pathways, including HIF-1alpha downregulation in prostate cancer, JAK/STAT modulation in irradiated testicular tissue, and Nrf2-GPX4 elevation in endothelial cells. Western blotting, reporter assays, and phospho-specific antibodies can be used to monitor these responses. These methods connect GO:0098626 activity to disease-relevant phenotypes.
How CRISPR Can Be Used to Study GO:0098626 methylseleninic acid reductase activity
Knockout
CRISPR knockout of candidate reductases can test whether a specific gene is required for GO:0098626 activity. In yeast, knocking out genes involved in selenium metabolism can reveal whether MSA-to-methylselenol conversion and subsequent protein aggregation are abolished. In mammalian cells, knockout of GPX4 or Nrf2 can test downstream dependencies of MSA action.
Point Mutation
Point mutation knock-in can be used to dissect the catalytic residues of the enzyme responsible for GO:0098626. By introducing mutations that alter NADPH binding or substrate recognition, researchers can determine which residues are essential for the reaction. Such models are valuable for separating catalytic activity from other functions of the protein.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous locus allows visualization and immunoprecipitation of the enzyme catalyzing GO:0098626. This approach can reveal subcellular localization and interaction partners under MSA treatment. Tagged knock-in models also enable monitoring of enzyme abundance in response to selenium availability.
Overexpression
Overexpression of the candidate reductase can enhance methylselenol production and amplify downstream effects such as protein aggregation or redox signaling. In cancer models, overexpression of antioxidant genes like GPX4 can protect against MSA-induced ferroptosis, while overexpression of pro-oxidant enzymes may sensitize cells. Overexpression models help establish causality between GO:0098626 activity and phenotype.
How EDITGENE Supports methylseleninic acid reductase activity Research
Researchers studying methylseleninic acid reductase activity-related genes often need to determine whether a candidate gene is causally involved in the reduction of MSA to methylselenol, or whether it merely correlates with selenium response. Establishing causality requires precise genetic tools that can remove, modify, or amplify the gene of interest in relevant cell models. EDITGENE provides these tools to accelerate mechanistic studies of GO:0098626 and its disease connections.
Contact EDITGENE today to design your custom CRISPR model for methylseleninic acid reductase activity research.
Frequently Asked Questions About methylseleninic acid reductase activity
What is methylseleninic acid reductase activity?
It is a molecular_function (GO:0098626) that catalyzes the reaction NADPH + H+ + CH3SeO2H = NADP+ + CH3SeOH + H2O, converting methylseleninic acid to methylselenol.
What is the GO ID for methylseleninic acid reductase activity?
The GO ID is GO:0098626, and the ontology aspect is molecular_function.
What reaction does GO:0098626 catalyze?
It catalyzes the NADPH-dependent reduction of methylseleninic acid (CH3SeO2H) to methylselenol (CH3SeOH), producing NADP+ and water.
What genes are involved in methylseleninic acid reductase activity?
Genes involved include selenium-metabolizing reductases, GPX4, Nrf2, HIF1A, and JAK/STAT pathway components, based on studies of MSA and methylselenol.
Why is methylselenol important in cancer prevention?
Methylselenol is a monomethylated selenium metabolite considered critical for the cancer-preventive effects of methylseleninic acid.
Does methylseleninic acid cause protein aggregation?
Yes, in Saccharomyces cerevisiae, methylselenol produced in vivo from MSA or dimethyl diselenide induces toxic protein aggregation.
How does MSA affect ferroptosis?
MSA elevates the Nrf2-GPX4 axis and relieves endothelial dysfunction and ferroptosis induced by arsenic exposure.
Does MSA affect HIF-1alpha in prostate cancer?
Yes, MSA downregulates hypoxia-inducible factor-1alpha in invasive prostate cancer.
Can MSA protect against radiation damage?
MSA has a potential protective effect against gamma-irradiation-induced testicular damage in rats, with impact on the JAK/STAT pathway.
How can researchers study GO:0098626 in the lab?
Researchers can use NADPH oxidation assays, selenium metabolite profiling, protein aggregation assays, and CRISPR knockout or overexpression models to study this activity.
Conclusion
GO:0098626 methylseleninic acid reductase activity defines the NADPH-dependent conversion of methylseleninic acid to methylselenol, a reaction central to selenium chemoprevention and redox biology. Its product, methylselenol, has been linked to anticancer effects, protein aggregation, ferroptosis relief, and modulation of HIF-1alpha and JAK/STAT signaling. Understanding this activity provides a mechanistic framework for interpreting selenium responses in health and disease. For researchers, GO:0098626 offers a precise molecular target for genetic and biochemical interrogation. CRISPR knockout, point mutation, knock-in, and overexpression models, combined with metabolic and signaling assays, can establish causality and reveal new therapeutic opportunities in cancer prevention and redox-related diseases.
References
- 1. Dauplais M et al.. 2021. Methylselenol Produced In Vivo from Methylseleninic Acid or Dimethyl Diselenide Induces Toxic Protein Aggregation in Saccharomyces cerevisiae.. Int J Mol Sci 22(5) PMID: 33668124
- 2. Ip C et al.. 2000. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.. Cancer Res 60(11):2882-6 PMID: 10850432
- 3. Díaz-Argelich N et al.. 2017. Novel Methylselenoesters as Antiproliferative Agents.. Molecules 22(8) PMID: 28767087
- 4. Cai Z et al.. 2025. Methylseleninic Acid Elevating the Nrf2-GPX4 Axis Relieves Endothelial Dysfunction and Ferroptosis Induced by Arsenic Exposure.. J Agric Food Chem 73(12):7445-7455 PMID: 40071728
- 5. Gawish RA et al.. 2020. The potential effect of methylseleninic acid (MSA) against γ-irradiation induced testicular damage in rats: Impact on JAK/STAT pathway.. Arch Biochem Biophys 679:108205 PMID: 31758927
- 6. Abdulah R et al.. 2005. Chemical forms of selenium for cancer prevention.. J Trace Elem Med Biol 19(2-3):141-50 PMID: 16325529
- 7. Sinha I et al.. 2012. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.. Int J Cancer 130(6):1430-9 PMID: 21500193
- 8. Bevinakoppamath S et al.. 2021. Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer.. Front Pharmacol 12:618172 PMID: 33935708
